Scarica l'app Stockscreener
4.07
1.21%
-0.05
Dopo l'orario di chiusura:
4.15
0.08
+1.97%
Ars Pharmaceuticals Inc Borsa (SPRY) Ultime notizie
Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals - GlobeNewswire
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
SPRY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 - Morningstar
Join Class Action to Recover Losses from ARS Pharmaceuticals, Inc. (SPRY)Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
Eric Karas proposes selling 100,000 ARS Pharmaceuticals (SPRY) shares after a $69.8K September sale. - Stock Titan
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. LawsuitSPRY - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY - FinancialContent
Portnoy Law Firm Announces Class Action on Behalf of ARS Pharmaceuticals, Inc. Investors - GlobeNewswire
SPRY Deadline: SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit - herald-dispatch.com
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY - GlobeNewswire Inc.
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Tigo Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Class Action Alert: Levi & Korsinsky Reminds ARS Pharmaceuticals (SPRY) Investors of October 5, 2026 Deadline - ACCESS Newswire
SPRY Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (SPRY) Investors to Seek Counsel Before the October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action - TMX Newsfile
Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (NASD - The National Law Review
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 – ARS Pharmaceuticals, Inc. (SPRY) - ACCESS Newswire
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY) - ACCESS Newswire
SPRY INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Class Action Filed Against ARS Pharmaceuticals, Inc. (SPRY) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Kaplan Fox Encourages ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to Contact the Firm Before the Deadline on October 5, 2026 - Barchart.com
Robbins LLP Reminds SPRY Stockholders of the Pending - GlobeNewswire
SPRY STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY) InvestorsContact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
Securities Lawsuit Alert: ARS Pharmaceuticals, Inc. (SPRY)Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with ... - Black Hills Pioneer
Shareholders of ARS Pharmaceuticals, Inc. (SPRY): Protect Your Rights Before October 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASD - The National Law Review
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm Before Lead Plaintiff Deadline on October 5, 2026 - Barchart.com
Did You Lose Money on ARS Pharmaceuticals, Inc. (SPRY)? Levi & Korsinsky Urges Investors to Act Before October 5, 2026 - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming DeadlinesSPRY - PR Newswire
Bragar Eagel & Squire, P.C. Reminds ARS Pharmaceuticals - GlobeNewswire
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026ARS Pharmaceuticals, Inc. (SPRY) - ACCESS Newswire
Securities Class Action Lawsuit Filed Against ARS Pharmaceuticals, Inc. (SPRY)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
SPRY Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in ARS Pharmaceuticals Inc. Securities Class ActionContact SueWallSt - PR Newswire
SPRY UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 - PR Newswire
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm to Learn About Their Legal Rights - The Globe and Mail
Class Action Lawsuit Filed: ARS Pharmaceuticals, Inc. (SPRY)Join by October 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
SPRY ALERT: Securities Fraud Class Action Launched Against ARS Pharmaceuticals, Inc.October 5, 2026 Deadline - ACCESS Newswire
October 5, 2026 Deadline Approaching: Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)Contact Levi & Korsinsky - ACCESS Newswire
Kaplan Fox Alerts Investors to an Upcoming Deadline of October 5, 2026 in the ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Securities Class Action - Barchart.com
SPRY Stock Tanks Over 23% After-Hours — ARS Pharmaceuticals Reports No New Major Insurance Wins For Neffy - Stocktwits
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionSPRY - TMX Newsfile
SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action NoticeContact Levi & Korsinsky - PR Newswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Investors Urged to Contact Levi & Korsinsky For Information Before October 5, 2026ARS Pharmaceuticals, Inc. (SPRY) - ACCESS Newswire
Kaplan Fox Alerts ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to Seek Leadership in a Securities Fraud Lawsuit by October 5, 2026 - NewMediaWire
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of ARS Pharmaceuticals Inc. to Contact the Firm Today! - ACCESS Newswire
Kaplan Fox & Kilsheimer LLP Alerts ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to the Lead Plaintiff Deadline on October 5, 2026 - NewMediaWire
Recover Investment Losses: Class Action Initiated Against ARS Pharmaceuticals, Inc. (SPRY) - ACCESS Newswire
Kaplan Fox & Kilsheimer LLP Encourages ARS Pharmaceuticals Inc. (NASDAQ: SPRY) Investors to Contact the Firm Before October 5, 2026 - The Globe and Mail
SPRY Stockholders with Large Losses Should Contact Robbins LLP About Leading the ARS Pharmaceuticals Inc. Class Action Before the October 5, 2026 Deadline - Morningstar
SPRY Shareholders Have Opportunity to Lead ARS Pharmaceuticals Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
SPRY Shareholders Have Opportunity to Lead ARS Pharmaceuticals In - The National Law Review
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
SPRY SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds AR - The National Law Review
Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against ARS Pharmaceuticals Inc. (NASDAQ: SPRY) and Lead Plaintiff Deadline on October 5, 2026 - FinancialContent
SPRY INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SPRY Shareholder Alert: ARS Pharmaceuticals Inc. Securities Class Action LawsuitInvestors Should Contact SueWallSt - PR Newswire
SPRY SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ARS Pharmaceuticals Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
SPRY DEADLINE: Levi & Korsinsky Reminds ARS Pharmaceuticals Inc. Investors of Upcoming Securities Class Action Deadline - PR Newswire
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR - GlobeNewswire
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):